Asunto(s)
Fístula Bronquial , Enfermedades Pleurales , Enfisema Subcutáneo , Humanos , Fístula Bronquial/etiología , Fístula Bronquial/diagnóstico por imagen , Aspergilosis Pulmonar Invasiva/complicaciones , Aspergilosis Pulmonar Invasiva/diagnóstico por imagen , Pleura/patología , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico por imagen , Fístula del Sistema Respiratorio/etiología , Fístula del Sistema Respiratorio/complicaciones , Fístula del Sistema Respiratorio/diagnóstico por imagen , Enfisema Subcutáneo/etiología , Enfisema Subcutáneo/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Femenino , AdultoRESUMEN
BACKGROUND: There are currently no data on the relationship between frailty and mortality in pleural disease. Understanding the relationship between frailty and outcomes is increasingly important for clinicians to guide decisions regarding investigation and management. This study aims to explore the relationship between all-cause mortality and frailty status in patients with pleural disease. METHODS: In this retrospective analysis of a prospectively collected observational cohort study, outpatients presenting to the pleural service at a tertiary centre in Bristol, UK with a radiologically confirmed, undiagnosed pleural effusion underwent comprehensive assessment and were assigned a final diagnosis at 12 months. The modified frailty index (mFI) was calculated and participants classified as frail (mFI ≥ 0.4) or not frail (mFI ≤ 0.2). RESULTS: 676 participants were included from 3rd March 2008 to 29th December 2020. The median time to mortality was 490 days (IQR 161-1595). A positive association was found between 12-month mortality and frailty (aHR = 1.72, 95% CI 1.02-2.76, p = 0.025) and age ≥ 80 (aHR = 1.80, 95% CI 1.24-2.62, p = 0.002). Subgroup analyses found a stronger association between 12-month mortality and frailty in benign disease (aHR = 4.36, 95% CI 2.17-8.77, p < 0.0001) than in all pleural disease. Malignancy irrespective of frailty status was associated with an increase in all-cause mortality (aHR = 10.40, 95% CI 6.01-18.01, p < 0.0001). CONCLUSION: This is the first study evaluating the relationship between frailty and outcomes in pleural disease. Our data demonstrates a strong association between frailty and 12-month mortality in this cohort. A malignant diagnosis is an independent predictor of 12-month mortality, irrespective of frailty status. Frailty was also strongly associated with 12-month mortality in patients with a benign underlying cause for their pleural disease. This has clinical relevance for pleural physicians; evaluating patients' frailty status and its impact on mortality can guide clinicians in assessing suitability for invasive investigation and management. TRIAL REGISTRATION: This study is registered with the Health Research Authority (REC reference 08/H0102/11) and the NIHR Portfolio (Study ID 8960).
Asunto(s)
Fragilidad , Enfermedades Pleurales , Humanos , Estudios Retrospectivos , Estudios de Cohortes , Enfermedades Pleurales/complicaciones , Pacientes , Complicaciones Posoperatorias/etiología , Factores de RiesgoRESUMEN
BACKGROUND: Pancreaticopleural fistula is a rare complication of pancreatitis and poses diagnostic and therapeutic challenges. This case report sheds light on the unique challenges posed by pancreaticopleural fistula as a rare complication of pancreatitis. The aim is to contribute valuable insights to the scientific literature by presenting a case involving a middle-aged man with acute necrotizing pancreatitis and associated pleural effusion. CASE PRESENTATION: A 41-year-old Asian male with a history of pancreatitis and chronic alcohol use presented with severe dyspnea, chest pain, and left-sided pleural effusion. Elevated serum amylase lipase levels and imaging confirmed acute necrotizing pancreatitis with a computed tomography severity index of 8/10. Magnetic resonance cholangiopancreatography revealed pancreatic necrosis and pseudocyst formation and findings suggestive of pancreaticopleural fistula. The patient was then treated with octreotide therapy. CONCLUSION: The management of pancreaticopleural fistula demands a comprehensive and individualized approach. Recognition guided by high clinical suspicion coupled with appropriate investigations and a careful balance between medical, endoscopic, and surgical interventions is crucial for achieving favorable outcomes. This case report adds to the scientific literature by providing insights into the complexities of pancreaticopleural fistula and emphasizing the importance of personalized strategies in its management.
Asunto(s)
Pancreatitis Aguda Necrotizante , Enfermedades Pleurales , Derrame Pleural , Fístula del Sistema Respiratorio , Adulto , Humanos , Masculino , Colangiopancreatografia Retrógrada Endoscópica , Fístula Pancreática/complicaciones , Fístula Pancreática/diagnóstico por imagen , Pancreatitis Aguda Necrotizante/complicaciones , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico por imagen , Derrame Pleural/diagnóstico por imagen , Derrame Pleural/etiología , Derrame Pleural/terapia , Fístula del Sistema Respiratorio/diagnóstico por imagen , Fístula del Sistema Respiratorio/etiologíaAsunto(s)
Fístula Bronquial , Empiema Pleural , Absceso Pulmonar , Enfermedades Pleurales , Ultrasonografía , Humanos , Masculino , Fístula Bronquial/diagnóstico por imagen , Fístula Bronquial/complicaciones , Empiema Pleural/diagnóstico por imagen , Absceso Pulmonar/diagnóstico por imagen , Absceso Pulmonar/complicaciones , Enfermedades Pleurales/diagnóstico por imagen , Enfermedades Pleurales/complicaciones , Sistemas de Atención de Punto , Pruebas en el Punto de Atención , Ultrasonografía/métodos , AdultoRESUMEN
We present a 19-year-old woman, a case of Lemierre syndrome, who presented with fever, sore throat, and left shoulder pain. Imaging revealed a thrombus in the right internal jugular vein, multiple nodular shadows below both pleura with some cavitations, right lung necrotizing pneumonia, pyothorax, abscess in the infraspinatus muscle, and multiloculated fluid collections in the left hip joint. After inserting a chest tube and administering urokinase for the pyothorax, a bronchopleural fistula was suspected. The fistula was identified based on clinical symptoms and computed tomography scan findings. If a bronchopleural fistula is present, thoracic lavage should not be performed as it may cause complications such as contralateral pneumonia due to reflux.
Asunto(s)
Fístula Bronquial , Empiema Pleural , Síndrome de Lemierre , Enfermedades Pleurales , Neumonía , Femenino , Humanos , Adulto Joven , Adulto , Síndrome de Lemierre/complicaciones , Síndrome de Lemierre/diagnóstico , Fístula Bronquial/complicaciones , Fístula Bronquial/diagnóstico por imagen , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico por imagen , Empiema Pleural/complicaciones , Empiema Pleural/diagnóstico por imagenRESUMEN
Thoracic ultrasound (TU) has rapidly gained popularity over the past 10 years. This is in part because ultrasound equipment is available in many settings, more training programmes are educating trainees in this technique, and ultrasound can be done rapidly without exposure to radiation. The aim of this review is to present the most interesting and innovative aspects of the use of TU in the study of thoracic diseases. In pleural diseases, TU has been a real revolution. It helps to differentiate between different types of pleural effusions, guides the performance of pleural biopsies when necessary and is more cost-effective under these conditions, and assists in the decision to remove thoracic drainage after talc pleurodesis. With the advent of COVID19, the use of TU has increased for the study of lung involvement. Nowadays it helps in the diagnosis of pneumonias, tumours and interstitial diseases, and its use is becoming more and more widespread in the Pneumology ward. In recent years, TU guided biopsies have been shown to be highly cost-effective, with other advantages such as the absence of radiation and the possibility of being performed at bedside. The use of contrast in ultrasound to increase the cost-effectiveness of these biopsies is very promising. In the study of the mediastinum and peripheral pulmonary nodules, the introduction of echobronchoscopy has brought about a radical change. It is a fully established technique in the study of lung cancer patients. The introduction of elastography may help to further improve its cost-effectiveness. In critically-ill patients, diaphragmatic ultrasound helps in the assessment of withdrawal of mechanical ventilation, and is now an indispensable tool in the management of these patients. In neuromuscular patients, ultrasound is a good predictor of impaired lung function. Currently, in Neuromuscular Disease Units, TU is an indispensable tool. Ultrasound study of the intercostal musculature is also effective in the study of respiratory function, and is widely used in Respiratory Rehabilitation. In Intermediate Care Units, thoracic ultrasound is indispensable for patient management. In these units there are ultrasound protocols for the management of patients with acute dyspnoea that have proven to be very effective.
Asunto(s)
Enfermedades Pleurales , Derrame Pleural Maligno , Enfermedades Torácicas , Humanos , Derrame Pleural Maligno/etiología , Pleurodesia/métodos , Enfermedades Pleurales/diagnóstico por imagen , Enfermedades Pleurales/terapia , Enfermedades Pleurales/complicaciones , Enfermedades Torácicas/diagnóstico por imagen , PleuraRESUMEN
Pyopneumothorax with bronchopleural fistula is a rare complication of lung infection. We herein report a case of pyopneumothorax with bronchopleural fistula caused by Porphyromonas gingivalis infection, a common pathogenic pathogen of periodontitis, in a 49-year-old man with periodontitis. The patient was admitted with respiratory failure. Pleural puncture yielded a lot of gas continually and foul-smelling light brown pus, which was found to be caused due to infection with P. gingivalis by the metagenomic next generation sequencing (mNGS) and anaerobic culture.
Asunto(s)
Fístula Bronquial , Empiema Pleural , Periodontitis , Enfermedades Pleurales , Neumotórax , Masculino , Humanos , Persona de Mediana Edad , Porphyromonas gingivalis , Periodontitis/complicaciones , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico , Fístula Bronquial/complicaciones , Neumotórax/complicacionesAsunto(s)
Fístula Bronquial , Absceso Pulmonar , Enfermedades Pleurales , Humanos , Absceso Pulmonar/complicaciones , Absceso Pulmonar/diagnóstico por imagen , Absceso Pulmonar/cirugía , Fístula Bronquial/diagnóstico por imagen , Fístula Bronquial/etiología , Fístula Bronquial/cirugía , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico por imagen , Enfermedades Pleurales/cirugía , Pulmón , NeumonectomíaRESUMEN
BACKGROUND: Pleuropulmonary amebiasis is the second most common form of extraintestinal invasive amebiasis, but cases that include bronchopleural fistula are rare. CASE PRESENTATION: A 43-year-old male was referred to our hospital for liver abscess, right pleural effusion, and body weight loss. He was diagnosed with a bronchopleural fistula caused by invasive pleuropulmonary amebiasis and human immunodeficiency virus (HIV) infection. After initial medical treatment for HIV infection and invasive amebiasis, he underwent pulmonary resection of the invaded lobe. Intraoperative inspection revealed a fistula of the right basal bronchus in the perforated lung abscess cavity, but the diaphragm was intact. The patient was discharged on postoperative day 3 and was in good condition at the 1-year follow-up. CONCLUSIONS: Clinicians should be aware that pleuropulmonary amebiasis can cause a bronchopleural fistula although it is very rare.
Asunto(s)
Amebiasis , Fístula Bronquial , Infecciones por VIH , Enfermedades Pleurales , Derrame Pleural , Masculino , Humanos , Adulto , Fístula Bronquial/diagnóstico por imagen , Fístula Bronquial/etiología , Fístula Bronquial/cirugía , Infecciones por VIH/complicaciones , Amebiasis/complicaciones , Amebiasis/diagnóstico , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/cirugíaRESUMEN
Endometriosis is a benign, inflammatory disease characterized by the presence of dysfunctional endometrial tissue outside the uterus. Typically confined to the pelvis, endometriosis is frequently associated with pain, dysmenorrhea, and infertility. Rarely, endometrial tissue has been documented to implant within the lung parenchyma and involve both parietal and visceral pleura of the thorax. Manifestations of thoracic endometriosis include catamenial pneumothorax, hemothorax, and hemoptysis. We present a case of thoracic endometriosis in a 43-year-old female who was found to have a loculated pleural effusion with an associated pleural nodule after gynecologic surgery. The patient underwent thoracotomy, decortication, and nodule excision. Pathology of the pleural nodule showed evidence of endometrial tissue within the parietal pleural. Thoracic endometriosis is a medical problem that is frequently undiagnosed and encountered by the practicing surgeon. Early diagnosis reduces both disease progression and late complications, allowing for early initiation of appropriate medical and surgical therapy.
Asunto(s)
Endometriosis , Enfermedades Pleurales , Neumotórax , Femenino , Humanos , Adulto , Endometriosis/complicaciones , Endometriosis/diagnóstico , Endometriosis/cirugía , Hemoptisis/complicaciones , Hemoptisis/patología , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico , Neumotórax/etiología , PleuraAsunto(s)
Fístula Bronquial , Enfermedades Pleurales , Humanos , Fístula Bronquial/diagnóstico por imagen , Fístula Bronquial/etiología , Fístula Bronquial/cirugía , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico por imagen , Enfermedades Pleurales/cirugía , NeumonectomíaAsunto(s)
Fístula Bronquial , Absceso Pulmonar , Enfermedades Pleurales , Humanos , Absceso Pulmonar/diagnóstico por imagen , Absceso Pulmonar/terapia , Siliconas , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/terapia , Fístula Bronquial/diagnóstico por imagen , Fístula Bronquial/terapia , Fístula Bronquial/complicaciones , Tórax , Neumonectomía/efectos adversosRESUMEN
Nontuberculous mycobacterial lung disease usually manifests as a chronic pulmonary infection. We herein report a fatal case of Mycobacterium avium pleurisy in a man with a refractory bronchopleural fistula that led to rapidly progressive pneumonia. A post-mortem transbronchial biopsy was performed. Histopathology revealed an acute lung injury pattern and epithelioid granulomas. Variable number tandem repeat analyses and drug susceptibility testing revealed Mycobacterium avium had acquired macrolide resistance during chemotherapy with rifampicin, ethambutol, and clarithromycin. Clinicians should be aware that Mycobacterium avium pleurisy with bronchopleural fistula can lead to fatal pneumonia, especially in patients with persistently positive cultures despite multidrug treatment.
Asunto(s)
Fístula , Infección por Mycobacterium avium-intracellulare , Mycobacterium tuberculosis , Enfermedades Pleurales , Pleuresia , Insuficiencia Respiratoria , Humanos , Masculino , Antibacterianos/uso terapéutico , Autopsia , Farmacorresistencia Bacteriana , Macrólidos/uso terapéutico , Pruebas de Sensibilidad Microbiana , Mycobacterium avium , Complejo Mycobacterium avium , Infección por Mycobacterium avium-intracellulare/complicaciones , Infección por Mycobacterium avium-intracellulare/diagnóstico , Infección por Mycobacterium avium-intracellulare/tratamiento farmacológico , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico , Pleuresia/tratamiento farmacológico , Insuficiencia Respiratoria/tratamiento farmacológicoRESUMEN
Unilateral hyperhidrosis is an uncommon manifestation, and the majority of cases have been attributed to neurological diseases. There are few cases of unilateral hyperhidrosis associated with thoracic malignant tumors. We herein report a 74-year-old Japanese man with squamous cell carcinoma of the lung who presented with unilateral hyperhidrosis in the right thoracic area as one of the first clinical manifestations. We should consider the possibility of pleural diseases, including metastatic lung cancer, when encountering patients presenting with unilateral thoracic hyperhidrosis.
Asunto(s)
Carcinoma de Células Escamosas , Hiperhidrosis , Neoplasias Pulmonares , Enfermedades Pleurales , Masculino , Humanos , Anciano , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/diagnóstico por imagen , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/diagnóstico por imagen , Enfermedades Pleurales/complicaciones , Hiperhidrosis/complicaciones , PulmónRESUMEN
Background: Pleural disorders in novel coronavirus disease 2019 (COVID-19), responsible for the deaths of more than 6.7 million people worldwide, are relatively uncommon and underappreciated findings. The severity of the pleural disease in these patients correlates with the treatment outcome and overall prognosis. Objective: We aim to review our experience with treatment modalities and prognosis in 45 patients with COVID-19, who were treated at our Clinic between April 2020 and October 2021. Methods: We conducted a retrospective, single-center, cross-sectional study. Demographic data, the type of thoracosurgical intervention(s), and treatment outcome for 45 patients included in this study were recorded for every patient. We analyzed the type and number of treatment modalities according to the pleural disorder, and the outcome of the treatment. Results: Pneumothorax was the most common COVID-19-related pleural disorder, followed by the pleural effusion. Tube thoracostomy was the mainstay of treatment, performed in 84.4% of patients with unilateral pleural complications. In total, 20% of our patients were on mechanical ventilation, and all of them had a fatal outcome. We found statistical significance in comparison to the percentage of fatal outcomes between patients treated with and without mechanical ventilation (p=0.000). Conclusion: COVID-19-related pleural disorders are prognostic markers of disease progression. Mechanically ventilated patients who require tube thoracostomy have an unfavorable prognosis.
Asunto(s)
COVID-19 , Enfermedades Pleurales , Derrame Pleural , Humanos , COVID-19/complicaciones , Estudios Transversales , Enfermedades Pleurales/complicaciones , Derrame Pleural/etiología , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
Background: Necrotizing pneumonia rarely occurs in children, but when it does it can be complicated by bronchopleural fistula, empyema, pneumothorax, sepsis, and acute respiratory distress syndrome (ARDS). Antimicrobial therapy is the cornerstone of its management; however, surgery is necessary in some cases. Ideally, surgical interventions are kept to a minimum, but this is not always possible if there is a mass effect from air and fluid in the pleural space, pulmonary necrosis leading to massive hemoptysis, uncontrolled sepsis, or difficulties with assisted ventilation. Case Presentation: Herein we present a patient with refractory pyopneumothorax and ARDS due to pneumococcal necrotizing pneumonia complicated by a bronchopleural fistula. The patient's clinical condition deteriorated despite antibiotics, surgical drainage, and assisted ventilation. Owing to pneumothorax with a high percentage of air leakage, bilateral diffuse collapse of the lungs, and insufficient oxygenation, surgical treatment was considered, but because of the patient's lack of tolerance for surgery due to hemodynamic reasons and the complications associated with surgery, medical treatment was determined to be more appropriate. Surfactant treatment was administered to the patient, resulting in significant clinical improvement. Conclusion: To the best of our knowledge, this is the first report of the use of surfactant to treat ARDS due to necrotizing pneumonia. Based on the presented case, we think surfactant can be considered as a salvage treatment for such patients.
Asunto(s)
Fístula Bronquial , Empiema Pleural , Enfermedades Pleurales , Neumonía Necrotizante , Neumonía Neumocócica , Neumotórax , Síndrome de Dificultad Respiratoria , Sepsis , Antibacterianos/uso terapéutico , Fístula Bronquial/complicaciones , Fístula Bronquial/cirugía , Niño , Empiema Pleural/complicaciones , Empiema Pleural/tratamiento farmacológico , Humanos , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/tratamiento farmacológico , Neumonía Necrotizante/complicaciones , Neumonía Necrotizante/tratamiento farmacológico , Neumonía Neumocócica/complicaciones , Neumonía Neumocócica/diagnóstico , Neumonía Neumocócica/tratamiento farmacológico , Neumotórax/complicaciones , Neumotórax/tratamiento farmacológico , Síndrome de Dificultad Respiratoria/complicaciones , Síndrome de Dificultad Respiratoria/tratamiento farmacológico , Sepsis/complicaciones , Sepsis/tratamiento farmacológico , Streptococcus pneumoniae , TensoactivosRESUMEN
BACKGROUND: Combination intrapleural fibrinolytic and enzyme therapy (IET) has been established as a therapeutic option in pleural infection. Despite demonstrated efficacy, studies specifically designed and adequately powered to address complications are sparse. The safety profile, the effects of concurrent therapeutic anticoagulation, and the nature and extent of nonbleeding complications remain poorly defined. RESEARCH QUESTION: What is the bleeding complication risk associated with IET use in pleural infection? STUDY DESIGN AND METHODS: This was a multicenter, retrospective observational study conducted in 24 centers across the United States and the United Kingdom. Protocolized data collection for 1,851 patients treated with at least one dose of combination IET for pleural infection between January 2012 and May 2019 was undertaken. The primary outcome was the overall incidence of pleural bleeding defined using pre hoc criteria. RESULTS: Overall, pleural bleeding occurred in 76 of 1,833 patients (4.1%; 95% CI, 3.0%-5.0%). Using a half-dose regimen (tissue plasminogen activator, 5 mg) did not change this risk significantly (6/172 [3.5%]; P = .68). Therapeutic anticoagulation alongside IET was associated with increased bleeding rates (19/197 [9.6%]) compared with temporarily withholding anticoagulation before administration of IET (3/118 [2.6%]; P = .017). As well as systemic anticoagulation, increasing RAPID score, elevated serum urea, and platelets of < 100 × 109/L were associated with a significant increase in bleeding risk. However, only RAPID score and use of systemic anticoagulation were independently predictive. Apart from pain, non-bleeding complications were rare. INTERPRETATION: IET use in pleural infection confers a low overall bleeding risk. Increased rates of pleural bleeding are associated with concurrent use of anticoagulation but can be mitigated by withholding anticoagulation before IET. Concomitant administration of IET and therapeutic anticoagulation should be avoided. Parameters related to higher IET-related bleeding have been identified that may lead to altered risk thresholds for treatment.
Asunto(s)
Enfermedades Transmisibles , Empiema Pleural , Enfermedades Pleurales , Derrame Pleural , Humanos , Activador de Tejido Plasminógeno/efectos adversos , Fibrinolíticos/efectos adversos , Estudios Retrospectivos , Derrame Pleural/complicaciones , Enfermedades Pleurales/complicaciones , Hemorragia/inducido químicamente , Hemorragia/epidemiología , Terapia Enzimática , Empiema Pleural/tratamiento farmacológico , Empiema Pleural/epidemiología , Empiema Pleural/complicacionesRESUMEN
INTRODUCTION: Video-assisted thoracic surgery (VATS) for ipsilateral reoperations is controversial, because after the first surgical intervention, pleural adhesions occur frequently in the thoracic cavity and/or chest wall. This study assessed the usefulness of preoperative ultrasonography to reduce the incidence of lung injury at the time of the initial port insertion during secondary ipsilateral VATS. MATERIALS AND METHODS: This was a retrospective, single-center study. Nine patients who underwent thoracic surgery at Vanvitelli Hospitalfrom September 2019 to February 2022, were scheduled for a second VATS surgeryon ipsilateral lung, because of inconclusive intraoperative histologic examination. All nine patients underwent preoperative ultrasonography to assess the possible presence of pleural adhesions. We evaluated the lung sliding, since the presence of pleural adhesions does not permit to appreciate it. STATISTICAL ANALYSIS: Hard severe adhesions were observed in all nine patients without sliding lung sign (specificity 100%). In this series, the sensitivity, PPV, and NPV of the sliding lung sign were 93%, 100% and 94% respectively. RESULTS: The presence of the lung respiratory changes can be evaluated as the "sliding lung sign" by chest ultrasonography; we believe that the sliding lung sign might also predict intrathoracic adhesion. CONCLUSIONS: Preoperative detection of pleural adhesions using transthoracic ultrasonography was useful for ipsilateral secondary pulmonary resection patients undergoing VATS. Using preoperative ultrasonography can improve the safety and feasibility of placing the initial port in VATS.
Asunto(s)
Enfermedades Pleurales , Cirugía Torácica Asistida por Video , Humanos , Pulmón/diagnóstico por imagen , Pulmón/cirugía , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/diagnóstico por imagen , Enfermedades Pleurales/cirugía , Estudios Retrospectivos , Cirugía Torácica Asistida por Video/efectos adversos , Adherencias Tisulares/complicacionesRESUMEN
BACKGROUND AND OBJECTIVE: Intrapleural tissue plasminogen activator/deoxyribonuclease (tPA/DNase) therapy is increasingly used in pleural infection. Bleeding risks and costs associated with tPA remain the clinical concerns. Our dose de-escalation series aims to establish the lowest effective dosing regimen for tPA/DNase. This study assesses the intrapleural use of 2.5 mg tPA/5 mg DNase for pleural infection. METHODS: Consecutive patients with pleural infection treated with a starting regime of 2.5 mg tPA/5 mg DNase were included from two centres in Australia and UK. Escalation of tPA dose was permitted if clinical response was inadequate. RESULTS: Sixty-nine patients (mean age 61.0 years) received intrapleural 2.5 mg tPA/5 mg DNase. Most (88.4%) were treated successfully and discharged from hospital without surgery by 90 days. Patients received a median of 5 [interquartile range [IQR] = 3-6] doses of tPA/DNase. Total amount of tPA used per patient was 12.5 mg [median, IQR = 7.5-15.0]. Seventeen patients required dose escalation of tPA; most (n = 12) for attempted drainage of distant non-communicating locule(s). Treatment success was corroborated by clearance of pleural opacities on radiographs (from median 27.0% [IQR = 17.1-44.5] to 11.0% [IQR = 6.4-23.3] of hemithorax, p < 0.0001), increased pleural fluid drainage (1.98 L [median, IQR = 1.38-2.68] over 72 h following commencement of tPA/DNase) and reduction of serum C-reactive protein level (by 45.0% [IQR = 39.3-77.0] from baseline at day 5, p < 0.0001). Two patients required surgery. Six patients with significant comorbidities (e.g., advanced cancer) had ongoing infection when palliated and died. Two patients experienced self-limiting pleural bleeding and received blood transfusion. CONCLUSION: A starting intrapleural regime of 2.5 mg tPA/5 mg DNase, with up-titration if needed, can be effective and deserves further exploration.
Asunto(s)
Empiema Pleural , Enfermedades Pleurales , Derrame Pleural , Desoxirribonucleasas/uso terapéutico , Empiema Pleural/tratamiento farmacológico , Fibrinolíticos/uso terapéutico , Humanos , Persona de Mediana Edad , Enfermedades Pleurales/complicaciones , Enfermedades Pleurales/tratamiento farmacológico , Derrame Pleural/tratamiento farmacológico , Activador de Tejido Plasminógeno/uso terapéuticoRESUMEN
An open thoracic window involves the creation of a semi-permanent pleural-cutaneous connection to treat chronic organising empyemas, bronchopleural fistulas and postpneumonectomy empyemas in patients too ill for video-assisted thoracic surgery decortication. An Eloesser flap is a type of open thoracic window. Antibiotics have made the use of Eloesser flaps and other open thoracic windows for treatment of empyemas rare. Consequently, not much is known about the chronic complications of open thoracic windows. However, structural compromise of vasculature secondary to chronic inflammation has been previously proposed as a mechanism for spontaneous pulmonary haematomas related to anatomic deformation. We depict a case of spontaneous pulmonary arterial bleed presenting as chest wall haemorrhage due to a chronic modified Eloesser flap.